Poolbeg Pharma PLC (AIM: POLB)
London
· Delayed Price · Currency is GBP · Price in GBX 4.700
+0.100 (2.17%)
Jan 17, 2025, 3:57 PM GMT+1
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 23.25 million as of January 22, 2025. Its market cap has decreased by -52.31% in one year.
Market Cap
23.25M
Enterprise Value
13.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.70
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 23.25M, a decrease of -56.74%. That is a compound annual growth rate of -21.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 23.25M | -34.51% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.45B |
| Haleon | 33.80B |
| Smith & Nephew | 8.94B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |